LHC Group (NASDAQ:LHCG) Research Coverage Started at UBS Group

UBS Group assumed coverage on shares of LHC Group (NASDAQ:LHCG) in a report issued on Thursday, PriceTargets.com reports. The brokerage issued a neutral rating and a $170.00 price objective on the health services provider’s stock.

Other equities research analysts have also issued research reports about the company. Barclays lowered LHC Group from an overweight rating to an equal weight rating and reduced their price objective for the stock from $245.00 to $207.00 in a research report on Thursday, August 12th. Credit Suisse Group reduced their price objective on LHC Group from $255.00 to $252.00 and set an outperform rating on the stock in a research report on Tuesday, August 10th. Cowen began coverage on LHC Group in a research report on Thursday, September 9th. They issued an outperform rating and a $209.00 price target on the stock. Deutsche Bank Aktiengesellschaft reduced their price target on LHC Group from $260.00 to $245.00 and set a buy rating on the stock in a research report on Wednesday. Finally, Benchmark upped their price target on LHC Group from $250.00 to $260.00 and gave the company a buy rating in a research report on Friday, July 9th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of Buy and an average target price of $227.22.

Shares of LHCG opened at $160.27 on Thursday. The firm has a market capitalization of $5.08 billion, a PE ratio of 42.97, a price-to-earnings-growth ratio of 1.93 and a beta of 0.36. LHC Group has a 12-month low of $157.27 and a 12-month high of $236.81. The stock’s fifty day simple moving average is $185.84 and its 200-day simple moving average is $194.91.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings data on Wednesday, August 4th. The health services provider reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.07. The business had revenue of $545.91 million for the quarter, compared to analyst estimates of $547.93 million. LHC Group had a return on equity of 11.66% and a net margin of 5.49%. LHC Group’s quarterly revenue was up 12.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.23 EPS. As a group, equities analysts predict that LHC Group will post 6.45 EPS for the current fiscal year.

Several large investors have recently made changes to their positions in the company. Thrivent Financial for Lutherans lifted its stake in shares of LHC Group by 3.1% in the 2nd quarter. Thrivent Financial for Lutherans now owns 493,815 shares of the health services provider’s stock valued at $98,892,000 after purchasing an additional 14,998 shares during the period. Virtu Financial LLC acquired a new position in shares of LHC Group in the 2nd quarter valued at about $703,000. Bank of America Corp DE lifted its stake in shares of LHC Group by 17.4% in the 2nd quarter. Bank of America Corp DE now owns 382,001 shares of the health services provider’s stock valued at $76,499,000 after purchasing an additional 56,622 shares during the period. Parametric Portfolio Associates LLC lifted its stake in shares of LHC Group by 29.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 87,218 shares of the health services provider’s stock valued at $17,466,000 after purchasing an additional 19,750 shares during the period. Finally, Marshall Wace LLP lifted its stake in shares of LHC Group by 68.5% in the 2nd quarter. Marshall Wace LLP now owns 15,159 shares of the health services provider’s stock valued at $3,036,000 after purchasing an additional 6,163 shares during the period. 92.14% of the stock is currently owned by institutional investors.

LHC Group Company Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Further Reading: Why Invest in High-Yield Dividend Stocks?

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.